Home/Filings/4/0001209191-20-020665
4//SEC Filing

Tucker Edwin Jonathan 4

Accession 0001209191-20-020665

CIK 0001759425other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 4:47 PM ET

Size

6.5 KB

Accession

0001209191-20-020665

Insider Transaction Report

Form 4
Period: 2020-03-19
Tucker Edwin Jonathan
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2020-03-19$9.91/sh+2,000$19,8183,500 total
  • Purchase

    Common Stock

    2020-03-20$11.90/sh+2,500$29,7406,000 total
Footnotes (1)
  • [F1]The weighted average purchase price for the transaction reported was $11.896, and the range of prices were between $11.88 and $11.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1
  • filerCIK 0001792296

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 4:47 PM ET
Size
6.5 KB